From bytes to bedside: Data integration and computational biology for translational cancer research

PLoS Computational Biology

Volumn 3, Issue 2, 2007, Pages 0153-0163

  Mathew, Jomol P ^a,e   Taylor, Barry S ^b,c,g   Bader, Gary D ^c,d   Pyarajan, Saiju ^e   Antoniotti, Marco ^f,h   Chinnaiyan, Arul M ^g   Sander, Chris ^c   Burakoff, Steven J ^e   Mishra, Bud ^e,h  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

^g UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^h NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DATA INTEGRATION; DIAGNOSIS; GENES;

BIOLOGICAL RESEARCH; CANCER RESEARCH; COMPUTATIONAL BIOLOGY; GENOME SCIENCE; GENOMIC DATA; MEDICAL PRACTICE; MOLECULAR DATA; MOLECULAR TECHNOLOGIES; SCIENCE TECHNOLOGIES; TRANSLATIONAL RESEARCH;

COMPUTATIONAL METHODS;

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CETUXIMAB; DNA; ERLOTINIB; GEFITINIB; IMATINIB; MICRORNA; RITUXIMAB; RNA; SMALL INTERFERING RNA; TRASTUZUMAB; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RESEARCH; CANCER THERAPY; CHROMOSOME 13; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG TARGETING; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEAD CANCER; HUMAN; LUNG NON SMALL CELL CANCER; MOLECULAR BIOLOGY; NECK CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PROTEIN MODIFICATION; REVIEW; TRANSCRIPTION REGULATION; UNSPECIFIED SIDE EFFECT; WHOLE BODY IMAGING; BIOLOGY; FACTUAL DATABASE; MEDICAL RESEARCH; METABOLISM; METHODOLOGY; NEOPLASM; ONCOLOGY; PATHOPHYSIOLOGY; RESEARCH; SYSTEM ANALYSIS;

BIOMEDICAL RESEARCH; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; MEDICAL ONCOLOGY; NEOPLASM PROTEINS; NEOPLASMS; RESEARCH; RESEARCH DESIGN; SYSTEMS INTEGRATION;

EID: 33847253388     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.0030012     Document Type: Review

References (102)

1. von Mehren M, Adams GP, Weiner LM (2003) Monoclonal antibody therapy for cancer. Annu Rev Med 54: 343-369.
2. FDA (2004) Challenge and opportunity on the critical path to new medical products. US Federal Drug Administration. Available: http://www. fda.gov/oc/initiatives/criticalpath/whitepaper.pdf. Accessed 25 December 2006.
3. Fabian MA, Biggs WH III, Treiber DK, Atteridge CE, Azimioara MD, et al. (2005) A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 23: 329-336.
4. McNeil N, Ried T (2000) Novel molecular cytogenetic techniques for identifying complex chromosomal rearrangements: Technology and applications in molecular medicine. Expert Rev Mol Med 2000: 1-14.
5. Baldwin C, Garnis C, Zhang L, Rosin MP, Lam WL (2005) Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65: 7561-7567.
6. Rauch A, Ruschendorf F, Huang J, Trautmann U, Becker C, et al. (2004) Molecular karyotyping using an SNP array for genomewide genotyping. J Med Genet 41: 916-922.
7. Consortium TIH (2003) The International HapMap Project. Nature 426: 789-796.
8. Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6: 597-610.
9. Schena M, Shalon D, Davis RW, Brown PO (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270: 467-470.
10. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14: 1675-1680.
11. Brenner S, Johnson M, Bridgham J, Golda G, Lloyd DH, et al. (2000) Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat Biotechnol 18: 630-634.
12. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, et al. (1999) Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286: 531-537.
13. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, et al. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826.
14. Blais A, Dynlacht BD (2005) Constructing transcriptional regulatory networks. Genes Dev 19: 1499-1511.
15. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, et al. (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235.
16. Scherf U, Ross DT, Waltham M, Smith LH, Lee JK, et al. (2000) A gene expression database for the molecular pharmacology of cancer. Nat Genet 24: 236-244.
17. Creighton CJ, Bromberg-White JL, Misek DE, Monsma DJ, Brichory F, et al. (2005) Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation. Mol Cancer Res 3: 119-129.
18. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, et al. (2002) Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 20: 301-305.
19. Mann M, Ong SE, Gronborg M, Steen H, Jensen ON, et al. (2002) Analysis of protein phosphorylation using mass spectrometry: Deciphering the phosphoproteome. Trends Biotechnol 20: 261-268.
20. Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ, et al. (2002) Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. MolCell Proteomics 1: 791-804.
21. Stover DR, Caldwell J, Marto J, Root K, Mestan J, et al. (2004) Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts. Clinical Proteomics 1: 69-80.
22. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, et al. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1: 376-386.
23. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, et al. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-1169.
24. Chaurand P, Schwartz SA, Reyzer ML, Caprioli RM (2005) Imaging mass spectrometry: Principles and potentials. Toxicol Pathol 33: 92-101.
25. Ptacek J, Devgan G, Michaud G, Zhu H, Zhu X, et al. (2005) Global analysis of protein phosphorylation in yeast. Nature 438: 679-684.
26. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551-3567.
27. Yates JR III, Eng JK, McCormack AL, Schieltz D (1995) Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem 67: 1426-1436.
28. Keller A, Nesvizhskii AI, Kolker E, Aebersold R (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74: 5383-5392.
29. Nesvizhskii AI, Keller A, Kolker E, Aebersold R (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646-4658.
30. Anderson DC, Li W, Payan DG, Noble WS (2003) A new algorithm for the evaluation of shotgun peptide sequencing in proteomics: Support vector machine classification of peptide MS/MS spectra and SEQUEST scores. J Proteome Res 2: 137-146.
31. Ruvkun G, Wightman B, Ha I (2004) The 20 years it took to recognize the importance of tiny RNAs. Cell 116: S93-S96, and 92 pages following.
32. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
33. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
34. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
35. Bartel DP (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
36. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2(11): e363.
37. Cary MP, Bader GD, Sander C (2005) Pathway information for systems biology. FEBS Lett 579: 1815-1820.
38. Nicholson JK, Wilson ID (2003) Opinion: Understanding "global" systems biology: Metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2: 668-676.
39. Cheng LL, Burns MA, Taylor JL, He W, Halpern EF, et al. (2005) Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res 65: 3030-3034.
40. Chen JH, Enloe BM, Weybright P, Campbell N, Dorfman D, et al. (2002) Biochemical correlates of thiazolidinedione-induced adipocyte differentiation by high-resolution magic angle spinning NMR spectroscopy. Magn Reson Med 48: 602-610.
41. Kupfer A, Kupfer H (2003) Imaging immune cell interactions and functions: SMACs and the immunological synapse. Semin Immunol 15: 295-300.
42. Reinhardt RL, Jenkins MK (2003) Whole-body analysis of T cell responses. Curr Opin Immunol 15: 366-371.
43. Shakhar G, Lindquist RL, Skokos D, Dudziak D, Huang JH, et al. (2005) Stable T cell-dendritic cell interactions precede the development of both tolerance and immunity in vivo. Nat Immunol 6: 707-714.
44. Bousso P, Robey EA (2004) Dynamic behavior of T cells and thymocytes in lymphoid organs as revealed by two-photon microscopy. Immunity 21: 349-355.
45. Zuo Y, Yang G, Kwon E, Gan WB (2005) Long-term sensory deprivation prevents dendritic spine loss in primary somatosensory cortex. Nature 436: 261-265.
46. Presley JF (2005) Imaging the secretory pathway: The past and future impact of live cell optical techniques. Biochim Biophys Acta 1744: 259-272.
47. Piantadosi S (2005) Clinical trials: A methodological perspective. 2nd edition. New York: Wiley. 720 p.
48. Duffaud F, Therasse P (2000) New guidelines to evaluate the response to treatment in solid tumors. Bull Cancer 87: 881-886.
49. Therasse P, Le Cesne A, Van Glabbeke M, Verweij J, Judson I (2005) RECIST versus WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma. Eur J Cancer 41: 1426-1430.
50. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A 101: 9309-9314.
51. Segal E, Friedman N, Koller D, Regev A (2004) A module map showing conditional activity of expressionmodules incancer. Nat Genet 36: 1090-1098.
52. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, et al. (2005) Mining for regulatory programs in the cancer transcriptome. Nat Genet 37: 579-583.
53. Rhodes DR, Chinnaiyan AM (2005) Integrative analysis of the cancer transcriptome. Nat Genet 37: S31-S37.
54. Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, et al. (2005) Global approach to the diagnosis of leukemia using gene expression profiling. Blood 106: 1189-1198.
55. Paez J, Sellers WR (2003) PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 115: 145-167.
56. Taron M, Ichinose Y, Rosell R, Mok T, Massuti B, et al. (2005) Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas. Clin Cancer Res 11: 5878-5885.
57. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, et al. (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10: 1140-1151.
58. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102: 13550-13555.
59. Dahlquist KD, Salomonis N, Vranizan K, Lawlor SC, Conklin BR (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat Genet 31: 19-20.
60. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, et al. (2003) MAPPFinder: Using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 4: R7.
61. Pradines J, Rudolph-Owen L, Hunter J, Leroy P, Cary M, et al. (2004) Detection of activity centers in cellular pathways using transcript profiling. J Biopharm Stat 14: 701-721.
62. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. (2005) A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037.
63. Ideker T, Ozier O, Schwikowski B, Siegel AF (2002) Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 18: S233-S240.
64. Antoniotti M, Ramakrishnan N, Mishra B (2005) GOALIE, a common lisp application to discover "Kripke Models": Redescribing biological processes from time-course data. Proceedings of the International Lisp Conference; 19-22 June 2005; Stanford, California, United States. Available: http://bioinformatics.nyu.edu/~marcoxa/publications/TLBIO/ARM-ILC-2005.pdf. Accessed 25 December 2006.
65. Hwang D, Rust AG, Ramsey S, Smith JJ, Leslie DM, et al. (2005) A data integration methodology for systems biology. Proc Natl Acad Sci U S A 102: 17296-17301.
66. Lee HK, Hsu AK, Sajdak J, Qin J, Pavlidis P (2004) Coexpression analysis of human genes across many microarray data sets. Genome Res 14: 1085-1094.
67. Chen KC, Csikasz-Nagy A, Gyorffy B, Val J, Novak B, et al. (2000) Kinetic analysis of a molecular model of the budding yeast cell cycle. Mol Biol Cell 11: 369-391.
68. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6.
69. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644-648.
70. Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, et al. (2005) Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8: 393-406.
71. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, et al. (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1: 304-313.
72. Chen G, Gharib TG, Wang H, Huang CC, Kuick R, et al. (2003) Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci U S A 100: 13537-13542.
73. Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, et al. (2003) Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci U S A 100: 605-610.
74. Shoubridge EA (2001) Cytochrome c oxidase deficiency. Am J Med Genet 106: 46-52.
75. Zhu Z, Yao J, Johns T, Fu K, De Bie I, et al. (1998) SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 20: 337-343.
76. Lee N, Daly MJ, Delmonte T, Lander ES, Xu F, et al. (2001) A genomewide linkage-disequilibrium scan localizes the Saguenay-Lac-Saint-Jean cytochrome oxidase deficiency to 2p16. Am J Hum Genet 68: 397-409.
77. Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436: 117-122.
78. Baudis M, Cleary ML (2001) Progenetix.net: An online repository for molecular cytogenetic aberration data. Bioinformatics 17: 1228-1229.
79. Knutsen T, Gobu V, Knaus R, Padilla-Nash H, Augustus M, et al. (2005) The interactive online SKY/M-FISH & CGH database and the Entrez cancer chromosomes search database: Linkage of chromosomal aberrations with the genome sequence. Genes Chromosomes Cancer 44: 52-64.
80. Mitelman FJB, Mertens F, editors (2006) Mitelman Database of Chromosome Aberrations in Cancer. Available: http://cgap.nci.nih.gov/Chromosomes/Mitelman. Accessed 3 January 2007.
81. Grunau C, Renault E, Rosenthal A, Roizes G (2001) MethDB - A public database for DNA methylation data. Nucleic Acids Res 29: 270-274.
82. Amoreira C, Hindermann W, Grunau C (2003) An improved version of the DNA Methylation database (MethDB). Nucleic Acids Res 31: 75-77.
83. Bamford S, Dawson E, Forbes S, Clements J, Pettett R, et al. (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91: 355-358.
84. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
85. Parkinson H, Sarkans U, Shojatalab M, Abeygunawardena N, Contrino S, et al. (2005) ArrayExpress - A public repository for microarray gene expression data at the EBI. Nucleic Acids Res 33: D553-D555.
86. Sherlock G, Hernandez-Boussard T, Kasarskis A, Binkley G, Matese JC, et al. (2001) The Stanford Microarray Database. Nucleic Acids Res 29: 152-155.
87. Omenn GS (2005) Exploring the human plasma proteome. Proteomics 5: 3223, 3225.
88. Craig R, Cortens JP, Beavis RC (2004) Open source system for analyzing, validating, and storing protein identification data. J Proteome Res 3: 1234-1242.
89. Martens L, Hermjakob H, Jones P, Adamski M, Taylor C, et al. (2005) PRIDE: The proteomics identifications database. Proteomics 5: 3537-3545.
90. Desiere F, Deutsch EW, Nesvizhskii AI, Mallick P, King NL, et al. (2005) Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol 6: R9.
91. Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, et al. (2005) A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4: 1920-1932.
92. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M (2004) The KEGG resource for deciphering the genome. Nucleic Acids Res 32: D277-D280.
93. Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, et al. (2005) Computational prediction of human metabolic pathways from the complete human genome. Genome Biol 6: R2.
94. Joshi-Tope G, Gillespie M, Vastrik I, D'Eustachio P, Schmidt E, et al. (2005) Reactome: A knowledgebase of biological pathways. Nucleic Acids Res 33: D428-D432.
95. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, et al. (2005) The PANTHER database of protein families, subfamilies, functions, and pathways. Nucleic Acids Res 33: D284-D288.
96. Bader GD, Betel D, Hogue CW (2003) BIND: The Biomolecular Interaction Network Database. Nucleic Acids Res 31: 248-250.
97. Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK, et al. (2003) Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res 13: 2363-2371.
98. Bader GD, Heilbut A, Andrews B, Tyers M, Hughes T, et al. (2003) Functional genomics and proteomics: Charting a multidimensional map of the yeast cell. Trends Cell Biol 13: 344-356.
99. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, et al. (2003) TRANSFAC: Transcriptional regulation, from patterns to profiles. 31: 374-378.
100. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, et al. (2006) BioGRID: A general repository for interaction datasets. Nucleic Acids Res 34: D535-D539.
101. Spellman PT, Miller M, Stewart J, Troup C, Sarkans U, et al. (2002) Design and implementation of microarray gene expression markup language (MAGE-ML). Genome Biol 3: RESEARCH0046.
102. Hermjakob H, Montecchi-Palazzi L, Bader G, Wojcik J, Salwinski L, et al. (2004) The HUPO PSI's molecular interaction format - A community standard for the representation of protein interaction data. Nat Biotechnol 22: 177-183.